FindTrial
Sign In

Inhalatorial sedation in patient with SAH versus conventional intravenus sedation - GAS

Inhalatorial sedation in patient with SAH versus conventional intravenus sedation - GAS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2008-008143-24-IT
Enrollment
Unknown
Registered
2009-02-09
Start date
2009-02-12
Completion date
Unknown
Last updated
2012-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sub-arachnoid haemorrage

Interventions

Pharmaceutical Form: Solution for infusion INN or Proposed INN: Propofol Concentration unit: % percent Concentration type: equal Concentration number: 1- Pharmaceutical Form: Nebuliser solution INN o

Sponsors

AZIENDA OSPEDALIERA SAN GERARDO DI MONZA
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - Diagnosis of aSAH - indication to DVE positioning - clinical indication to sedation and assisted ventilation - indication to ICP and CBF monitoring - age >18 Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: - documented cranical hypertension (ICP>18) not controller by liquor drainage - age<18.

Design outcomes

Primary

MeasureTime frame
Main Objective: Evaluate the Cerebral Blood flow variation associated to isoflurano sedation versus propofol sedation;Secondary Objective: nd;Primary end point(s): Evaluate the Cerebral Blood flow variation associated to isoflurano sedation versus propofol sedation—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026